2018
DOI: 10.1097/tp.0000000000002332
|View full text |Cite
|
Sign up to set email alerts
|

Tacrolimus-Induced Cholestatic Hepatitis in a Patient With Liver Transplant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…[29,30] It could even lead to cholestasis and hepatotoxicity after liver transplantation. [31] Most of these risks are due to its molecular interactions at inappropriate doses. [32] For tacrolimus, various dispersion concentrations in donor liver tissue may bring different consequences; therefore, the crucial factor of tacrolimus therapy may be the balance between immunosuppression and toxic overdose.…”
Section: Discussionmentioning
confidence: 99%
“…[29,30] It could even lead to cholestasis and hepatotoxicity after liver transplantation. [31] Most of these risks are due to its molecular interactions at inappropriate doses. [32] For tacrolimus, various dispersion concentrations in donor liver tissue may bring different consequences; therefore, the crucial factor of tacrolimus therapy may be the balance between immunosuppression and toxic overdose.…”
Section: Discussionmentioning
confidence: 99%